The Aporia · GLP-1 drugs can ‘reverse biologic aging’ by two to three years, say drug companies

GLP-1 drugs can ‘reverse biologic aging’ by two to three years, say drug companies

Read the original at New York Post ↗

Cite

APA MLA Chicago

Sacks, R. (2026, October 11). GLP-1 drugs can ‘reverse biologic aging’ by two to three years, say drug companies. New York Post. https://nypost.com/2026/10/11/health/glp-1-drugs-can-reverse-biologic-aging-by-two-to-three-years/

Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.

Quick Summary

At an Aging Research & Drug Discovery conference, pharmaceutical companies presented findings from trials showing that GLP-1 drugs can reverse biological aging by two to three years for overweight or diabetic patients. Novo and Eli Lilly conducted studies involving thousands of participants using various methods like proteomic and epigenetic clocks to measure age prediction through blood samples. Geneticist Steve Horvath noted that a reduction of up to two years is significant, suggesting these drugs may act as geroprotectors. However, it remains unclear if the anti-aging effects would be consistent in healthy individuals without obesity or diabetes.

Written by AI on 2026-10-11, from this article's own text only (the story summary below draws on all the coverage).

AI analysis

Story summary

During the Aging Research & Drug Discovery conference, pharmaceutical companies presented findings from trials on GLP-1 drugs like Ozempic and Wegovy, which are reversing biological aging in overweight or diabetic patients by around two to three years. Geneticist Steve Horvath, who invented "aging clocks," described the effect as a strong indicator that these drugs could be classified as geroprotectors—medications that slow or reverse aging biologically. For instance, Novo Nordisk conducted a study involving 10,052 people, where half were given semaglutide and the other half a placebo, measuring changes through proteomic clocks to assess age-related risks. Eli Lilly also performed a similar but smaller-scale study using epigenetic clocks on their drug tirzepatide. These results suggest that GLP-1 drugs may offer significant benefits in aging research despite potential side effects.

Written for “GLP-1 Drugs Reverse Aging” on 2026-11-05, grounded in this article and the 0 other(s) covering the same event.

Compared with similar articles

This article reads unscored and hedges 27% of its claims. Each row says how that neighbour differs.

Experimental skin cream linked to 2-year drop in biological age in early study Different event

Fox News

Hedges 3 of 27 claims Outlet record 68/100

“The articles describe different studies: one on GLP-1 drugs and another on an experimental skin cream, each with distinct methodologies and reported outcomes.”

WATCH: Measles, GLP-1s and anti-aging: How to protect your health Different event

ABC News (US)

Hedges 0 of 1 claims Outlet record 67/100

“Article A reports on findings presented at a conference about GLP-1 drugs reversing biological aging, while Article B discusses a broader topic including measles and GLP-1s in the context of health protection.”

Signals How these are calculated →

Claims extracted

sentences that state something as happening or true

Uncertain

27%

4 of 15 hedged ("reportedly", "may", "according to")

Leaning

not political

takes no side on a contested political question

Publisher signals

66/100

New York Post's corrections and hedging, across everything collected from it. Not a measure of accuracy.

Outlets on this story

Health

Same framing elsewhere

articles that frame the event the way this one does

Who wrote this

Rachel Sacks

39 article(s) here · 1 carrying a prediction

🔮 A disease that health officials have described as the fastest-spreading on record in Africa shows no signs of slowing down, and may soon afflict those outside the continent.

2026-11-02 · mixed framing · Officials warn ‘unprecedented’ disease outbreak is ‘very dire’: ‘All countries should know that they are not safe’

🔮 The estimated 40 million people who have diabetes may be prescribed a medication to manage blood sugar levels.

2026-11-01 · assertive framing · Common diabetes medications may trigger side effects that require even more drugs to fix: study

🔮 The good news is that an innovative treatment could not only replace the dental drill, but also spare those who brush off scheduling their next checkup.

2026-10-26 · speculative framing · Skip the dental drill — a simple liquid could stop cavities from progressing: study

🔮 The results of the phase 3 trial could offer hope for a disease that kills more than 97,000 people around the world each year.

2026-10-26 · assertive framing · New breakthrough in fight against devastating disease that kills 90K a year

🔮 A widespread problem, hair loss affects roughly 50 million men and 30 million women, and while there’s no special potion to reverse genetic or age-related decline, some products may slow down loss and promote regrowth.

2026-10-25 · mixed framing · Men battling baldness may soon have a new pill to turn to

🔮 Depressive symptoms may look similar, but there are various underlying causes.

2026-10-25 · mixed framing · What is ‘circadian’ depression? It may be the reason why you can’t sleep

🔮 The race is intended to give all kids the confidence boost that comes with crossing a finish line and hearing crowds cheering for them, with Collins noting that for some “it could be their first ever fitness event.”

2026-10-20 · assertive framing · Long Island fitness competition has race for kids as young as 8

🔮 And while a little meal before bedtime may curb your hunger in the short term, eating at the wrong time could increase the risk of a severe disease that causes permanent damage.

2026-10-19 · assertive framing · Love late-night snacking? It raises your risk of a serious disease by 20% to 30%

🔮 Massages may provide short-term relief for pain in the neck, shoulders, lower back and knees, as well as a part of supportive care for cancer patients.

2026-10-18 · assertive framing · You can now get a robot massage designed by Tom Brady

🔮 “The FDA should do whatever it possibly could do to get their hands on the actual drug that was injected by both of these patients,” associate professor at Harvard Medical School Pieter Cohen told CBS News.

2026-10-16 · mixed framing · Two people have died after taking bootleg versions of not-yet-on-the-market ‘triple G’ weight loss drug

Also by Rachel Sacks

Officials warn ‘unprecedented’ disease outbreak is ‘very dire’: ‘All countries should know that they are not safe’

2026-11-02 · New York Post

Common diabetes medications may trigger side effects that require even more drugs to fix: study

2026-11-01 · New York Post

Skip the dental drill — a simple liquid could stop cavities from progressing: study

2026-10-26 · New York Post

New breakthrough in fight against devastating disease that kills 90K a year

2026-10-26 · New York Post

Nothing else under this byline is closely related to this article, so these are simply their most recent.

All 39 articles by Rachel Sacks →

Claims (15 extracted, 4 hedged)

During the Aging Research & Drug Discovery conference, the pharmaceutical companies shared their findings from several trials on the effects the medications have on aging. asserted

medications → share → aging

And overweight or diabetic patients taking the medications saw a decreased age of around two or three years, a notable outcome according to one biological aging expert. uncertain

patients → take → expert

“Two years is a pretty strong effect, in my book,” geneticist Steve Horvath, the inventor of aging clocks, said, adding that the data suggests GLP-1 drugs “are actually what is known as geroprotectors, medications that slow or possibly even reverse biologic aging.” uncertain

that → age → aging

As part of their research, Novo took blood draws from 10,052 people, half on the drug semaglutide and half on a placebo. asserted

Novo → take → placebo

The blood — collected at the start of the study as well as months later — was then measured with “proteomic clocks,” which use levels of key proteins to predict a person’s age and risk of dying. asserted

which → collect → age

Eli Lilly performed a similar, yet smaller, study on their drug, tirzepatide, using “epigenetic” clocks that measure age by marking changes to a person’s DNA. asserted

that → perform → DNA

In the search for scientific remedies for aging, Novo’s drug semaglutide (sold under the names Ozempic and Wegovy) may be the closest solution. uncertain

drug → sell → names

The difference in aging varied widely, depending on which type of clock was used and what organ was tested. asserted

organ → vary → clock

For example, the drugs slowed down aging as much as four years in the case of a clock that looked at heart proteins. asserted

that → slow → proteins

Overall, though, both studies found that the drugs slowed down molecular time in a significant way. asserted

drugs → find → way

Multiple other studies have shown that GLP-1s improve health metrics like high blood pressure and cholesterol through a combination of weight loss and weight-independent mechanisms, both of which also affect biological aging. asserted

both → show → aging

However, it’s unclear whether they would have the same anti-aging effects on a healthy population as they did on patients with obesity or type 2 diabetes. uncertain

they → ’ → obesity

And while the medications do come with a host of side effects and adverse events, the research is pointing to a significant benefit in aging and longevity. “All the clocks are telling a consistent story that we’re seeing a reduction in age,” vice president for aging research at Lilly, Kevin Duffin, said during the conference. asserted

Duffin → come → conference

“It’s not like we’re going to reverse age by 30 years or something, but it’s a significant reduction. asserted

it → ’ → years

And more companies are investing in the anti-aging effects of the medications, with US agency ARPA-H putting $38 million toward a study that will look at whether semaglutide affects cognition, mobility and sensory acuity in healthy people over 60. asserted

semaglutide → invest → 60

💬Give feedback · no sign-in needed

Tell me what to work on

No sign-in needed for now. Your note is sent without a name, so it cannot be answered.

🕘History 🎫Support

Terms · Privacy · beta v2.0.0

Articles to 5 Nov 2026

GLP-1 drugs can ‘reverse biologic aging’ by two to three years, say drug companies

Quick Summary

AI analysis

Story

Compared with similar articles

Signals How these are calculated →

How this is being covered How these are calculated →

Publisher

Who wrote this

Topics

Subjects

Narrative

Claims (15 extracted, 4 hedged)